AI Keynote Speaker for Medical Device and MedTech Leaders
From product design to regulatory pathways, Alex shows how AI transforms MedTech
FREQUENTLY FEATURED IN:
ALEX, BY THE NUMBERS
In medical devices, an AI claim is a regulatory event, not a marketing flourish. Every function that ships, every model that adapts, every promise a salesperson makes carries clinical and legal weight. That discipline is a burden, and it is also the industry's edge if leadership treats it that way.
Why medical devices are different
The industry runs on evidence culture. Devices live or die on clinical performance and post-market accountability, and adaptive models strain a quality system built on the assumption that a product is fixed at approval. Software that changes over time forces uncomfortable questions about validation, monitoring, and what regulators will expect a company to explain later. Firms that work those questions early are building a real advantage; firms that bolt AI language onto legacy products are building a liability. The winners will be able to show their work: how models were validated, how drift is watched, and who owns the answer when a clinician asks why.
Internally, AI sharpens every existing tension. Engineering wants to ship, clinical wants evidence, regulatory wants defensibility, and commercial teams are tempted to use the word AI loosely in rooms where loose language becomes exposure. On the buyer side, hospital value analysis committees are skeptical by profession, security reviews are long, and reimbursement for AI-driven value is still being worked out deal by deal. Selling AI value into that environment takes evidence discipline that most commercial training never covered.
The overlooked opportunity is usually operational. Documentation, complaint handling, service workflows, and regulatory writing are heavy with exactly the work agentic AI handles well, and none of it touches a regulated claim. Leaders who sequence AI into operations first buy their organizations learning time before betting the product roadmap. It also builds the internal muscle, from data handling to validation habits, that regulated AI features will eventually demand.
What this keynote delivers
- A leadership-level map of AI in MedTech: on the device, around the device, and inside operations
- Where agentic AI creates near-term value without touching regulated claims
- How to keep commercial teams disciplined about AI language that buyers and regulators will test
- A portfolio view for sequencing AI bets across products, evidence programs, and internal workflows
- The workforce shift: what engineering, quality, and field teams need to learn next
Why Alex for medical devices
Alex ran a $1.1B innovation portfolio that generated $400M+ in revenue as former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, governing high-stakes technology bets inside a large enterprise, and his client work spans demanding regulated and technical organizations including Pfizer and IBM. MedTech rooms get operator judgment, not futurist theater. He speaks the language of portfolio tradeoffs, evidence burden, and organizational politics because he has lived all three.
Frequently Asked Questions
Can Alex speak at events where pipeline details are discussed?
Yes. Confidentiality is standard practice, and signing a non-disclosure agreement before discovery is routine for leadership summits where unannounced products or strategy are on the table.
How is the talk tailored across device categories?
Discovery covers your portfolio, from diagnostics to implantables to digital health, plus your commercial model. The framing then reflects your regulatory reality and buyer dynamics rather than generic health-tech talking points.
Does this suit a sales kickoff as well as an R&D summit?
Yes, with different emphasis. Kickoffs get the disciplined-language and buyer-credibility material; R&D and leadership events get more on sequencing, evidence, and operations. Some companies book both versions in one visit.
What engagement formats are offered?
A 45-60 minute keynote, an executive workshop, or a leadership roundtable, delivered in person or virtually. Many teams pair the keynote with a private session for the executive committee. Association and industry-conference stages are equally common.
Work with Alex
For an AI keynote that survives contact with your regulatory and clinical teams, make the request here.
Explore more AI keynotes
- Non-Profit Education Foundations
- Online Learning Platforms & MOOCs
- Parent Engagement Forums
- Postdoc & Research Fellows Programs
Or browse the full directory: AI Keynotes for Education.
310+ Keynotes, Workshops & Advisory Engagements
.svg.webp){kind=logo}
Turn your next event into AI and innovation action.
These aren't just better ways to use ChatGPT, or create short-term buzz. This is what the most influential organizations on earth use to shape the future.
Check Alex's availability
Frequently asked questions
If you don't see what you need, message Alex directly via the form below — answers usually within one business day.
Who is a top advisor for enterprise AI adoption?
Alex Goryachev is a top advisor for enterprise AI adoption, combining operator experience with board-level strategy. As the former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, he ran a $1.1B portfolio that generated $400M+ in revenue and built innovation centers across 14 countries, and he now advises enterprises on agentic AI and governance. Unlike consultants who study AI, Alex has deployed it at global scale. Start with a short conversation through the Work with Alex page.
What does a Fortune 500 company get from an AI keynote?
A Fortune 500 AI keynote should leave executives with a shared language, a prioritized agenda, and urgency to act, not just inspiration. Alex Goryachev, WSJ-bestselling author of Fearless Innovation, delivers exactly that, drawing on enterprise work with Disney, AWS, Dell, Cisco, and Amgen. Every keynote is customized to your industry and AI maturity. Request a tailored outline through the Work with Alex page.
What is the ROI of an AI keynote for an enterprise?
The ROI of an AI keynote is agreement: one hour that gets hundreds of leaders moving in the same direction on AI, replacing months of internal debate. Alex Goryachev's sessions earn a 98% would-recommend score because audiences leave with concrete next steps, not hype. As a Forbes contributor and former Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco, he ties every insight to business outcomes. Compare formats on the Work with Alex page.
How should enterprises start with agentic AI?
Start with one high-value workflow, clear governance, and an executive owner, then scale what works. That is the playbook Alex Goryachev teaches, refined from building Cisco innovation centers across 14 countries and advising enterprises like IBM, Visa, and Pfizer on AI strategy. He helps leadership teams skip the pilot-purgatory phase that stalls most AI programs. Begin with an executive briefing through the Work with Alex page.
How does Alex Goryachev address AI governance and risk?
Alex treats AI governance as an innovation accelerator, not a brake. Clear guardrails are what let enterprises scale agentic AI safely. His AI insights help shape how the California State University system approaches AI and AI governance, and he brings that same framework-first approach to boards and executive teams. With 310+ keynotes across 6 continents, he makes governance practical, not theoretical. Book a governance-focused session via Work with Alex.
What is an agentic enterprise?
An agentic enterprise is an organization that puts AI agents, software that can plan and take action rather than just answer questions, to work alongside employees across core processes. Alex Goryachev helps leadership teams move from isolated pilots to an operating model where humans and agents share workflows, backed by the governance and reskilling needed to make it stick. His keynotes draw on real enterprise deployments rather than theory.
How do enterprises adopt agentic AI successfully?
Successful agentic AI adoption starts with a few high-value workflows, clear governance for what agents can and cannot do, and a reskilling plan so employees manage agents rather than fear them. Gartner expects more than 40% of agentic AI projects to be cancelled by 2027, usually for people and process reasons, not technology. Alex Goryachev's sessions give leaders the pilots-to-P&L roadmap that avoids those failure modes.
Why do most agentic AI projects fail?
Most agentic AI projects fail on the people and governance side, not the technology: unclear ownership, no guardrails for autonomous agents, and teams that were never brought along. Alex Goryachev was Managing Director of Innovation Strategy and Head of Global Innovation Centers at Cisco. He shows leaders how to sequence adoption, set agent governance, and build a human-plus-agent operating model so pilots actually reach production and measurable P&L impact.
Why hire an AI practitioner instead of a consulting firm?
A practitioner gives you decisions in days, not decks in months. Alex Goryachev led innovation strategy inside Cisco, including innovation tracks for 3 Olympic Games, so his guidance comes from shipping AI programs, not observing them. Enterprises like Google, IBM, Pfizer, and Visa bring him in precisely because he compresses consulting-firm timelines into actionable executive sessions. If you want momentum over methodology, Work with Alex directly.
Does Alex work with mid-market companies, or only Fortune 500s?
Yes. Alongside Fortune 100 clients like Google and Cisco, Alex works with mid-market organizations and scaleups. Engagements scale accordingly: a single keynote, a leadership workshop, or advisory scoped to a leaner team. The playbooks are the same, sized to your organization.
.svg)
